Compare TNDM & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNDM | GSBD |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2013 | 2013 |
| Metric | TNDM | GSBD |
|---|---|---|
| Price | $15.12 | $9.27 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 19 | 2 |
| Target Price | ★ $28.00 | $9.00 |
| AVG Volume (30 Days) | ★ 2.5M | 848.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 13.49% |
| EPS Growth | N/A | ★ 87.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,014,736,000.00 | N/A |
| Revenue This Year | $8.11 | N/A |
| Revenue Next Year | $11.85 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.93 | N/A |
| 52 Week Low | $10.00 | $8.65 |
| 52 Week High | $29.65 | $12.03 |
| Indicator | TNDM | GSBD |
|---|---|---|
| Relative Strength Index (RSI) | 40.98 | 53.55 |
| Support Level | $11.86 | $8.81 |
| Resistance Level | $15.75 | $9.25 |
| Average True Range (ATR) | 1.24 | 0.18 |
| MACD | -0.16 | 0.05 |
| Stochastic Oscillator | 0.28 | 72.52 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.